Sinopharm Group (1099.HK) Earnings Analysis
Sinopharm Group (1099.HK) next reports earnings on 2026-08-31, consensus EPS 1.26 HKD. Last quarter (2026-04-23) it beat with EPS 1.31 HKD vs 1.27 HKD est (+3.1%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 6.39.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1099.HK next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | 1.26 HKD |
| Revenue estimate | 329.05B |
1099.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 1.31 HKD | 1.27 HKD | +3.1% | Beat |
| 2025-08-21 | 1.21 HKD | 1.06 HKD | +14.2% | Beat |
| 2025-03-20 | 1.14 HKD | 1.5 HKD | -24% | Miss |
| 2024-10-25 | 1.28 HKD | 1.48 HKD | -13.5% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
1099.HK valuation and analyst view
| Trailing P/E | 6.39 |
|---|---|
| Trailing EPS | 2.285 HKD |
| Price / book | 0.54 |
| Dividend yield | 4.67% |
| Market cap | 53.02B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sinopharm Group (1099.HK)'s next earnings date?
Sinopharm Group is next scheduled to report on 2026-08-31, with a consensus EPS estimate of 1.26 HKD and revenue estimate of 329.05B.
Did 1099.HK beat earnings last quarter?
In its 2026-04-23 report, 1099.HK posted EPS of 1.31 HKD versus a 1.27 HKD estimate — a beat of 3.1%.
What is 1099.HK's earnings track record?
Over the last 4 reported quarters with consensus data, 1099.HK beat estimates 2 times (50%).
What is 1099.HK's current P/E ratio and EPS?
1099.HK trades at a trailing P/E of 6.39 on trailing EPS of 2.2847182862891433 HKD.
What do analysts rate 1099.HK?
1099.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.